These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


243 related items for PubMed ID: 17806130

  • 21. Synthesis and biological evaluation of cyclopropyl analogues of fosmidomycin as potent Plasmodium falciparum growth inhibitors.
    Devreux V, Wiesner J, Goeman JL, Van der Eycken J, Jomaa H, Van Calenbergh S.
    J Med Chem; 2006 Apr 20; 49(8):2656-60. PubMed ID: 16610809
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Synthesis and analysis of a fluorinated product analogue as an inhibitor for 1-deoxy-D-xylulose 5-phosphate reductoisomerase.
    Munos JW, Pu X, Liu HW.
    Bioorg Med Chem Lett; 2008 May 15; 18(10):3090-4. PubMed ID: 18078746
    [Abstract] [Full Text] [Related]

  • 26. α-Substituted β-oxa isosteres of fosmidomycin: synthesis and biological evaluation.
    Brücher K, Illarionov B, Held J, Tschan S, Kunfermann A, Pein MK, Bacher A, Gräwert T, Maes L, Mordmüller B, Fischer M, Kurz T.
    J Med Chem; 2012 Jul 26; 55(14):6566-75. PubMed ID: 22731758
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Non-mevalonate isoprenoid biosynthesis: enzymes, genes and inhibitors.
    Lichtenthaler HK.
    Biochem Soc Trans; 2000 Dec 26; 28(6):785-9. PubMed ID: 11171208
    [Abstract] [Full Text] [Related]

  • 30. Substitution of the phosphonic acid and hydroxamic acid functionalities of the DXR inhibitor FR900098: an attempt to improve the activity against Mycobacterium tuberculosis.
    Andaloussi M, Lindh M, Björkelid C, Suresh S, Wieckowska A, Iyer H, Karlén A, Larhed M.
    Bioorg Med Chem Lett; 2011 Sep 15; 21(18):5403-7. PubMed ID: 21824775
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. 1-Deoxy-D-xylulose 5-phosphate reductoisomerase (IspC) from Mycobacterium tuberculosis: towards understanding mycobacterial resistance to fosmidomycin.
    Dhiman RK, Schaeffer ML, Bailey AM, Testa CA, Scherman H, Crick DC.
    J Bacteriol; 2005 Dec 15; 187(24):8395-402. PubMed ID: 16321944
    [Abstract] [Full Text] [Related]

  • 33. Tools for discovery of inhibitors of the 1-deoxy-D-xylulose 5-phosphate (DXP) synthase and DXP reductoisomerase: an approach with enzymes from the pathogenic bacterium Pseudomonas aeruginosa.
    Altincicek B, Hintz M, Sanderbrand S, Wiesner J, Beck E, Jomaa H.
    FEMS Microbiol Lett; 2000 Sep 15; 190(2):329-33. PubMed ID: 11034300
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Molecular epidemiology of malaria in Cameroon. XXV. In vitro activity of fosmidomycin and its derivatives against fresh clinical isolates of Plasmodium falciparum and sequence analysis of 1-deoxy-D-xylulose 5-phosphate reductoisomerase.
    Tahar R, Basco LK.
    Am J Trop Med Hyg; 2007 Aug 15; 77(2):214-20. PubMed ID: 17690389
    [Abstract] [Full Text] [Related]

  • 36. Antimalarial activity of N(6)-substituted adenosine derivatives. Part 3.
    Herforth C, Wiesner J, Heidler P, Sanderbrand S, Van Calenbergh S, Jomaa H, Link A.
    Bioorg Med Chem; 2004 Feb 15; 12(4):755-62. PubMed ID: 14759735
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Synthesis and evaluation of 1-deoxy-D-xylulose 5-phosphate analogues as chelation-based inhibitors of methylerythritol phosphate synthase.
    Walker JR, Poulter CD.
    J Org Chem; 2005 Nov 25; 70(24):9955-9. PubMed ID: 16292827
    [Abstract] [Full Text] [Related]

  • 40. Synthesis and bioactivity of β-substituted fosmidomycin analogues targeting 1-deoxy-D-xylulose-5-phosphate reductoisomerase.
    Chofor R, Sooriyaarachchi S, Risseeuw MD, Bergfors T, Pouyez J, Johny C, Haymond A, Everaert A, Dowd CS, Maes L, Coenye T, Alex A, Couch RD, Jones TA, Wouters J, Mowbray SL, Van Calenbergh S.
    J Med Chem; 2015 Apr 09; 58(7):2988-3001. PubMed ID: 25781377
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 13.